Division of Nephrology, Kingston Health Sciences Center, Queen's University, Kingston, Ontario, Canada; Division of Nephrology, Stanford University School of Medicine, Stanford, Calif.
Division of Nephrology, Stanford University School of Medicine, Stanford, Calif.
J Thorac Cardiovasc Surg. 2020 Feb;159(2):477-486.e3. doi: 10.1016/j.jtcvs.2019.03.064. Epub 2019 Apr 4.
The study objective was to compare outcomes for patients with and without acute kidney injury during hospitalizations when left ventricular assist devices are implanted.
By using the National Inpatient Sample from 2008 to 2013, we identified patients with an International Classification of Diseases, Ninth Revision procedure code for left ventricular assist device implantation (37.66). We ascertained the presence of acute kidney injury and acute kidney injury requiring dialysis using validated International Classification of Diseases, Ninth Revision codes. We used logistic regression to examine the association of nondialysis-requiring acute kidney injury and acute kidney injury requiring dialysis with mortality, procedural complications, and discharge destination.
We identified 8362 patients who underwent left ventricular assist device implantation, of whom 3760 (45.0%) experienced nondialysis-requiring acute kidney injury and 426 (5.1%) experienced acute kidney injury requiring dialysis. In-hospital mortality was 3.9% for patients without acute kidney injury, 12.2% for patients with nondialysis-requiring acute kidney injury, and 47.4% for patients with acute kidney injury requiring dialysis. Patients with nondialysis-requiring acute kidney injury and acute kidney injury requiring dialysis had higher adjusted odds of mortality (3.24, 95% confidence interval [CI], 2.04-5.13 and 20.8, 95% CI, 9.7-44.2), major bleeding (1.38, 95% CI, 1.08-1.77 and 2.44, 95% CI, 1.47-4.04), sepsis (2.69, 95% CI, 1.93-3.75 and 5.75, 95% CI, 3.46-9.56), and discharge to a nursing facility (2.15, 95% CI, 1.51-3.07 and 5.89, 95% CI, 2.67-12.99).
More than 1 in 10 patients with acute kidney injury and approximately 1 in 2 patients with acute kidney injury requiring dialysis died during their hospitalization, with only 30% of patients with acute kidney injury requiring dialysis discharged to home. This information is necessary to support shared decision-making for patients with advanced heart failure and acute kidney injury.
本研究旨在比较左心室辅助装置植入患者在发生急性肾损伤与未发生急性肾损伤时的住院结局。
我们利用 2008 年至 2013 年全国住院患者样本,确定了国际疾病分类第 9 版手术编码为左心室辅助装置植入术(37.66)的患者。我们使用验证后的国际疾病分类第 9 版编码确定了急性肾损伤和需要透析的急性肾损伤的存在情况。我们使用逻辑回归分析检查了非透析需求的急性肾损伤和需要透析的急性肾损伤与死亡率、手术并发症和出院去向的关系。
我们确定了 8362 例接受左心室辅助装置植入术的患者,其中 3760 例(45.0%)发生了非透析需求的急性肾损伤,426 例(5.1%)发生了需要透析的急性肾损伤。无急性肾损伤患者的院内死亡率为 3.9%,非透析需求的急性肾损伤患者为 12.2%,需要透析的急性肾损伤患者为 47.4%。非透析需求的急性肾损伤和需要透析的急性肾损伤患者的死亡调整后比值比分别为 3.24(95%置信区间[CI],2.04-5.13)和 20.8(95%CI,9.7-44.2),大出血调整后比值比分别为 1.38(95%CI,1.08-1.77)和 2.44(95%CI,1.47-4.04),脓毒症调整后比值比分别为 2.69(95%CI,1.93-3.75)和 5.75(95%CI,3.46-9.56),出院至护理机构调整后比值比分别为 2.15(95%CI,1.51-3.07)和 5.89(95%CI,2.67-12.99)。
超过 1/10 的急性肾损伤患者和大约 1/2 需要透析的急性肾损伤患者在住院期间死亡,仅有 30%的需要透析的急性肾损伤患者出院回家。这些信息对于支持晚期心力衰竭和急性肾损伤患者的共同决策是必要的。